Bosnia and Herzegovina

Welcome! On this page you'll find all the latest legal news, publications and events for Bosnia and Herzegovina. To stay in touch with the latest developments, please bookmark this page on your mobile or register to receive eAlerts.

CMS is a major force in Bosnia and Herzegovina: to learn more, click here.

Recent Articles

  •  
    10/09/2024
    International

    CMS Annual Review of English Construction Law Developments: An International Perspective

    We are pleased to announce the publication of the 2024 edition of our internationally focused Annual Review of English Construction Law Developments. The Annual Review summarises key developments in English construction law over the previous calendar year including developments in related common law jurisdictions. The publication has been prepared with our international clients in mind and aims to provide a greater degree of background and analysis than our regular Law-Now alert service.This year’s edition has a strong focus on exclusion and limitation clauses, with more than half of the...
    Read more
  •  
    16/08/2024
    Europe

    CMS Data Protection Update EU and Germany, August 2024

    I.    The latest from the data protection authorities and current topics1.    AI Act: Legislative proceedings finalisedThe legislative proceedings for the AI Act have been completed and came into effect on 1 August 2024. The CMS homepage provides an overview: Looking ahead to the EU AI Act (cms.law). The data protection authorities have published the following notifications and are gearing up for their new duties: Statement 3/2024 of the European Data Protection Board (EDPB) on data protection authorities' role in the Artificial Intelligence (AI) Act...
    Read more
  •  
    13/08/2024
    Europe

    Antibody Appeals Uncovered

    Since the first approval of Muromonab-CD3 in 1986, antibodies have become progressively more common, frequently reaching a ‘blockbuster’ status. According to statistics provided by Statista in March, 5 out of 10 top-selling drugs were antibodies in 2023. Therefore, patents related to antibodies are now of considerable interest and significance to the pharmaceutical industry. They provide protection for commercially important inventions, spur further investment, and allow patients to benefit from these therapeutics. Our report provides a high-level analysis of the Board of Appeal decisions...
    Read more
  •  
    05/08/2024
    Europe

    TMO4+ and “First Ready, First Connected” – musings from the workgroup reports

    OverviewThe following is an update to our initial Law Now titled “TMO4+ and “First Ready, First Connected” – reforming a disorderly queue?” dated 29 May 2024 which primarily reported on CUSC Modification Proposals (“CMP”) 434 and 435 as they were originally set out in National Grid Electricity System Operator’s (“NGESO”) original proposal form.Since then, the connection reform process has continued at pace through a series of workgroup consultations, culminating in workgroup reports for the CMP 434 and 435 proposals being published on...
    Read more
  •  
    26/07/2024
    International

    EU AI Act – Focus on Enforcement: the EU governance structure

    On 1 August 2024, the Regulation laying down harmonised rules on Artificial Intelligence (AI Act) will enter into force. As a European regulation, the AI Act will apply directly in all 27 EU member states and is intended to make a significant contribution to achieving the European digital strategy (A Europe fit for the digital age). In this, the second article in our series on the implementation of the AI Act, we provide an overview of the European AI governance structure. Understanding this structure is important to understand the roles of the administrative bodies that will have oversight...
    Read more
  •  
    25/07/2024
    International

    EU anti-dumping investigations of Chinese glyoxylic acid imports

    On 25 July 2024, the EU opened an anti-dumping investigation concerning EU imports of glyoxylic acid originating in the People’s Republic of China, which could lead to substantial anti-dumping duties on future imports.The product under investigation for alleged dumping is glyoxylic acid (Chemical Abstracts Service (CAS) Number 298-12-4), of a purity of at least 95 % by dry weight, whether in solid form or as an aqueous solution with a concentration by weight higher than 40 % thereof.The product under investigation is currently classified under CN code ex 2918 30 00 (TARIC code 2918...
    Read more